XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Cumulative effect of a change in accounting
Adjusted Balance
Common Stock
Common Stock
Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Adjusted Balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Adjusted Balance
Accumulated Deficit
Accumulated Deficit
Cumulative effect of a change in accounting
Accumulated Deficit
Adjusted Balance
Treasury Stock
Treasury Stock
Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2018       36,921,000 36,921,000                  
Beginning balance at Dec. 31, 2018 $ (21,924) $ 1,547 $ (20,377) $ 371 $ 371 $ 343,955 $ 343,955 $ (4,531) $ (4,531) $ (361,023) $ 1,547 $ (359,476) $ (696) $ (696)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 27,525                 27,525        
Share-based compensation expense 13,414         13,414                
Issuance in connection with the exercise of stock options (in shares)       104,000                    
Issuance in connection with the exercise of stock options 1,099     $ 1   1,098                
Issuance of common stock upon vesting of restricted stock units (in shares)       435,000                    
Issuance of common stock upon vesting of restricted stock units       $ 4   (4)                
Effect of shares withheld to cover taxes (4,137)         (4,137)                
Total other comprehensive income (loss) (8,020)             (8,020)            
Ending balance (in shares) at Dec. 31, 2019       37,460,000 37,460,000                  
Ending balance at Dec. 31, 2019 9,504 $ (239) $ 9,265 $ 376 $ 376 354,326 $ 354,326 (12,551) $ (12,551) (331,951) $ (239) $ (332,190) (696) $ (696)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 38,192                 38,192        
Share-based compensation expense $ 18,448         18,448                
Issuance in connection with the exercise of stock options (in shares) 7,193     7,000                    
Issuance in connection with the exercise of stock options $ 92         92                
Issuance of common stock upon vesting of restricted stock units (in shares)       712,000                    
Issuance of common stock upon vesting of restricted stock units 0     $ 7   (7)                
Effect of shares withheld to cover taxes (7,356)         (7,356)                
Total other comprehensive income (loss) $ (7,664)             (7,664)            
Ending balance (in shares) at Dec. 31, 2020 38,178,975     38,179,000                    
Ending balance at Dec. 31, 2020 $ 50,977     $ 383   365,503   (20,215)   (293,998)     (696)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 41,982                 41,982        
Share-based compensation expense $ 12,297         12,297                
Issuance in connection with the exercise of stock options (in shares) 240,129     129,000                    
Issuance in connection with the exercise of stock options $ 524     $ 2   522                
Issuance of common stock upon vesting of restricted stock units (in shares)       441,000                    
Issuance of common stock upon vesting of restricted stock units 0     $ 4   (4)                
Effect of shares withheld to cover taxes (4,674)         (4,674)                
Total other comprehensive income (loss) $ 9,065             9,065            
Ending balance (in shares) at Dec. 31, 2021 38,748,617     38,749,000                    
Ending balance at Dec. 31, 2021 $ 110,171     $ 389   $ 373,644   $ (11,150)   $ (252,016)     $ (696)